SLE is a particularly aggressive disease in children, and represents an unmet medical need. We have found that SLE is characterized by major alterations in the dendritic cell (DC) system, where uncontrolled IFN alpha release drives unabated activation/maturation of myeloid DCs. The ectopic presence of mature DCs in the circulation represents an attractive explanation for the breaking of tolerance towards self-components, the essence of SLE. We have also found that IFN-alpha is a powerful inducer of plasma cell differentiation and survival possibly contributing to the hypergammaglobulinemia observed in SLE patients. Our hypothesis is that SLE results from two combined alterations: one in the antigen presentation pathway, where an excess of IFN induces the unabated activation of DCs, and one in the B cell pathway where B cells generate an excess of autoreactive plasma cells. IFN-activated DCs are key factors in these processes by presenting nucleosomes to autoreactive B cells and allowing their expansion and differentiation. Three complementary though independent Aims have been designed to prove our hypothesis:
Aim 1 will determine the capacity of IFN-DCs (DCs made by culturing healthy monocytes with IFNa) and SLEs-DCs (DCs made by culturing healthy monocytes with SLE serum) to induce the differentiation of healthy and SLE B cells into plasma cells or their precursors.
Aim 2 will determine whether IFN-DCs and SLE-DCs loaded with apoptotic cells, preferentially select nuclear antigen specific B cells.
Aim 3 will analyze the in vivo interactions between IFN-DCs/SLEs-DCs and B cells in humanized mice . Ultimately these studies will further our understanding of SLE pathogenesis and help us identify better targets to treat SLE patients.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZAR1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Sw Medical Center Dallas
United States
Zip Code
Strauß, Romy; Rose, Thomas; Flint, Shaun M et al. (2017) Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic options. J Mol Med (Berl) 95:753-765
Orme, Jacob J; Du, Yong; Vanarsa, Kamala et al. (2016) Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE. Clin Immunol 169:58-68
Du, Yong; Wu, Tianfu; Zhou, Xin J et al. (2016) Blockade of CD354 (TREM-1) Ameliorates Anti-GBM-Induced Nephritis. Inflammation 39:1169-76
Huang, Qi-Quan; Perlman, Harris; Birkett, Robert et al. (2015) CD11c-mediated deletion of Flip promotes autoreactivity and inflammatory arthritis. Nat Commun 6:7086
Solow, Elizabeth Blair; Vongpatanasin, Wanpen; Skaug, Brian et al. (2015) Antinuclear Antibodies Are Associated With All-Cause Mortality and Cardiovascular Outcomes in the General Population. J Am Coll Cardiol 65:2669-2670
Arriens, Cristina; Hynan, Linda S; Lerman, Robert H et al. (2015) Placebo-controlled randomized clinical trial of fish oil's impact on fatigue, quality of life, and disease activity in Systemic Lupus Erythematosus. Nutr J 14:82
Min, So-Youn; Yan, Mei; Kim, Sang Bum et al. (2015) Green Tea Epigallocatechin-3-Gallate Suppresses Autoimmune Arthritis Through Indoleamine-2,3-Dioxygenase Expressing Dendritic Cells and the Nuclear Factor, Erythroid 2-Like 2 Antioxidant Pathway. J Inflamm (Lond) 12:53
Davis, Laurie S (2015) BiP, From Putting Out Fires to Fanning the Flames in Rheumatoid Arthritis. Arthritis Rheumatol 67:1147-50
Xiao, Feng; Waldrop, Shar L; Bronk, Steve F et al. (2015) Lipoapoptosis induced by saturated free fatty acids stimulates monocyte migration: a novel role for Pannexin1 in liver cells. Purinergic Signal 11:347-59
Ireland, Sara J; Monson, Nancy L; Davis, Laurie S (2015) Seeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10. Cytokine 73:236-44

Showing the most recent 10 out of 42 publications